Last week Zogenix, Inc., a pharmaceutical company that develops products for treating central nervous system disorders and pain, announced positive results from its pivotal Phase 3 efficacy study of Zohydro (hydrocodone bitartrate) extended-release capsules.
Hydrocodone is an opioid pain reliever used to treat moderate to severe pain. Currently in the U.S., hydrocodone is only available in immediate-release form and is always combined with acetaminophen. The purpose of including...
